Alzheimers Disease Research Outline

							[Type text]
                                                                                  Christina Boyd
                                                                             September 18, 2007
                                                                                         Seminar




                       Alzheimers Disease Research Outline
        1. Introduction
              A. What is Dementia?
                      Impaired memory
                      Severe decline in patients organizational skills.
              B. What is Alzheimers Disease?
                      Slow progressive brain disease
                      Increase accumalation of the production of beta- amyloid protein
                        which leads to nerve cell death.
              C. Development of Alzheimers Disease
                      Elderly due to age
                      Genetics
              D. Stages of Alzheimers
                      There are six developmental stages of Alzheimers
              E. Signs and Symptoms of Alzheimers Disease
                      Short term and long term memory loss
                      Personality changes
                      Disorientation
              F. The Causes of Alzheimers Disease
                      Amyloid Cascade Hypothesis
              G. Risk Factors of Alzheimers
                      APOE4 gene
                      Traumatic head injuries
                      Increased age
              H. Diagnosis of Alzheimers Disease
                      No imaging or blood test can determine Alzheimers
                      Clinical Evaluations of brain ex. CT Scan as well as MRI Imaging
              I. Prognosis of Alzheimers Disease
                      Progresses within two- twenty five years
                      Patients don’t die directly from Alzheimers other factors play a role.
              J. Treatment and Management of Alzheimers Disease
                      Two types of medications cholinesterase Inhibitors and partial
                        glutamente antagonists
        2. Conclusion
                      Greater understanding of Alzheimers and Risk factors
        3. References
[Type text]
                   Christina Boyd
              September 18, 2007
                          Seminar